Report Detail
Global Diabetic Neuropathy Market Insights, Forecast to 2025
- RnM2708160 |
- 06 May, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Growth in global diabetic neuropathy market is highly attributed to consistently increasing diabetic population across the globe linked with growing awareness among people is considered as major market driver for diabetic neuropathy market. Moreover, global market is primarily driven by changing lifestyle which has mostly resulted into unhealthy dietary habits and patterns. In addition, factors such as increasing aging population, rise in healthcare expenditure for diabetes, growing awareness about diabetes, and rise in R&D activities in drug discovery and development have contributed in the global growth. However, growth of this market is predominantly restrained by longer approval time for drugs and side effects and rising cost of diabetic neuropathy treatment. Also, stringent regulatory requirement and significant failure rate during the clinical trials expected to be the growth barriers in the years to come.
The global Diabetic Neuropathy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diabetic Neuropathy market based on company, product type, end user and key regions.
This report studies the global market size of Diabetic Neuropathy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetic Neuropathy in these regions.
This research report categorizes the global Diabetic Neuropathy market by top players/brands, region, type and end user. This report also studies the global Diabetic Neuropathy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Janssen Pharmaceuticals
Eli Lilly and Company
ACTAVIS
Cephalon
MEDA Pharma & Co. KG
GlaxoSmithKline
NeuroMetrix
Johnson and Johnson
Market size by Product
Peripheral Neuropathy
Autonomic Neuropathy
Proximal Neuropathy
Focal Neuropathy
Market size by End User
Hospitals
Clinics
Retail Pharmacy
Online Pharmacy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Diabetic Neuropathy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Diabetic Neuropathy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diabetic Neuropathy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Diabetic Neuropathy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Diabetic Neuropathy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetic Neuropathy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Diabetic Neuropathy Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Diabetic Neuropathy Market Size Growth Rate by Product
- 1.4.2 Peripheral Neuropathy
- 1.4.3 Autonomic Neuropathy
- 1.4.4 Proximal Neuropathy
- 1.4.5 Focal Neuropathy
- 1.5 Market by End User
- 1.5.1 Global Diabetic Neuropathy Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Retail Pharmacy
- 1.5.5 Online Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Diabetic Neuropathy Market Size
- 2.1.1 Global Diabetic Neuropathy Revenue 2014-2025
- 2.1.2 Global Diabetic Neuropathy Sales 2014-2025
- 2.2 Diabetic Neuropathy Growth Rate by Regions
- 2.2.1 Global Diabetic Neuropathy Sales by Regions
- 2.2.2 Global Diabetic Neuropathy Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Diabetic Neuropathy Sales by Manufacturers
- 3.1.1 Diabetic Neuropathy Sales by Manufacturers
- 3.1.2 Diabetic Neuropathy Sales Market Share by Manufacturers
- 3.1.3 Global Diabetic Neuropathy Market Concentration Ratio (CR5 and HHI)
- 3.2 Diabetic Neuropathy Revenue by Manufacturers
- 3.2.1 Diabetic Neuropathy Revenue by Manufacturers (2014-2019)
- 3.2.2 Diabetic Neuropathy Revenue Share by Manufacturers (2014-2019)
- 3.3 Diabetic Neuropathy Price by Manufacturers
- 3.4 Diabetic Neuropathy Manufacturing Base Distribution, Product Types
- 3.4.1 Diabetic Neuropathy Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Diabetic Neuropathy Product Type
- 3.4.3 Date of International Manufacturers Enter into Diabetic Neuropathy Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Diabetic Neuropathy Sales by Product
- 4.2 Global Diabetic Neuropathy Revenue by Product
- 4.3 Diabetic Neuropathy Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Diabetic Neuropathy Breakdown Data by End User
6 North America
- 6.1 North America Diabetic Neuropathy by Countries
- 6.1.1 North America Diabetic Neuropathy Sales by Countries
- 6.1.2 North America Diabetic Neuropathy Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Diabetic Neuropathy by Product
- 6.3 North America Diabetic Neuropathy by End User
7 Europe
- 7.1 Europe Diabetic Neuropathy by Countries
- 7.1.1 Europe Diabetic Neuropathy Sales by Countries
- 7.1.2 Europe Diabetic Neuropathy Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Diabetic Neuropathy by Product
- 7.3 Europe Diabetic Neuropathy by End User
8 Asia Pacific
- 8.1 Asia Pacific Diabetic Neuropathy by Countries
- 8.1.1 Asia Pacific Diabetic Neuropathy Sales by Countries
- 8.1.2 Asia Pacific Diabetic Neuropathy Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Diabetic Neuropathy by Product
- 8.3 Asia Pacific Diabetic Neuropathy by End User
9 Central & South America
- 9.1 Central & South America Diabetic Neuropathy by Countries
- 9.1.1 Central & South America Diabetic Neuropathy Sales by Countries
- 9.1.2 Central & South America Diabetic Neuropathy Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Diabetic Neuropathy by Product
- 9.3 Central & South America Diabetic Neuropathy by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Diabetic Neuropathy by Countries
- 10.1.1 Middle East and Africa Diabetic Neuropathy Sales by Countries
- 10.1.2 Middle East and Africa Diabetic Neuropathy Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Diabetic Neuropathy by Product
- 10.3 Middle East and Africa Diabetic Neuropathy by End User
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Diabetic Neuropathy Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Janssen Pharmaceuticals
- 11.2.1 Janssen Pharmaceuticals Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Janssen Pharmaceuticals Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Janssen Pharmaceuticals Diabetic Neuropathy Products Offered
- 11.2.5 Janssen Pharmaceuticals Recent Development
- 11.3 Eli Lilly and Company
- 11.3.1 Eli Lilly and Company Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Eli Lilly and Company Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Eli Lilly and Company Diabetic Neuropathy Products Offered
- 11.3.5 Eli Lilly and Company Recent Development
- 11.4 ACTAVIS
- 11.4.1 ACTAVIS Company Details
- 11.4.2 Company Business Overview
- 11.4.3 ACTAVIS Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 ACTAVIS Diabetic Neuropathy Products Offered
- 11.4.5 ACTAVIS Recent Development
- 11.5 Cephalon
- 11.5.1 Cephalon Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cephalon Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cephalon Diabetic Neuropathy Products Offered
- 11.5.5 Cephalon Recent Development
- 11.6 MEDA Pharma & Co. KG
- 11.6.1 MEDA Pharma & Co. KG Company Details
- 11.6.2 Company Business Overview
- 11.6.3 MEDA Pharma & Co. KG Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 MEDA Pharma & Co. KG Diabetic Neuropathy Products Offered
- 11.6.5 MEDA Pharma & Co. KG Recent Development
- 11.7 GlaxoSmithKline
- 11.7.1 GlaxoSmithKline Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline Diabetic Neuropathy Products Offered
- 11.7.5 GlaxoSmithKline Recent Development
- 11.8 NeuroMetrix
- 11.8.1 NeuroMetrix Company Details
- 11.8.2 Company Business Overview
- 11.8.3 NeuroMetrix Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 NeuroMetrix Diabetic Neuropathy Products Offered
- 11.8.5 NeuroMetrix Recent Development
- 11.9 Johnson and Johnson
- 11.9.1 Johnson and Johnson Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Johnson and Johnson Diabetic Neuropathy Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Johnson and Johnson Diabetic Neuropathy Products Offered
- 11.9.5 Johnson and Johnson Recent Development
12 Future Forecast
- 12.1 Diabetic Neuropathy Market Forecast by Regions
- 12.1.1 Global Diabetic Neuropathy Sales Forecast by Regions 2019-2025
- 12.1.2 Global Diabetic Neuropathy Revenue Forecast by Regions 2019-2025
- 12.2 Diabetic Neuropathy Market Forecast by Product
- 12.2.1 Global Diabetic Neuropathy Sales Forecast by Product 2019-2025
- 12.2.2 Global Diabetic Neuropathy Revenue Forecast by Product 2019-2025
- 12.3 Diabetic Neuropathy Market Forecast by End User
- 12.4 North America Diabetic Neuropathy Forecast
- 12.5 Europe Diabetic Neuropathy Forecast
- 12.6 Asia Pacific Diabetic Neuropathy Forecast
- 12.7 Central & South America Diabetic Neuropathy Forecast
- 12.8 Middle East and Africa Diabetic Neuropathy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Diabetic Neuropathy Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Diabetic Neuropathy . Industry analysis & Market Report on Diabetic Neuropathy is a syndicated market report, published as Global Diabetic Neuropathy Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Diabetic Neuropathy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
